Charles River Laboratories International Current Deferred Revenue (Quarterly) Trends

Charles River Laboratories International, Inc. (CRL)

200.19 -1.79 (-0.89%) USD | NYSE | Dec 31, 14:49

View Current Deferred Revenue (Quarterly) for CRL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Johnson & Johnson	--
Eli Lilly & Co.	--
Thermo Fisher Scientific, Inc.	Upgrade
IQVIA Holdings, Inc.	Upgrade
Medpace Holdings, Inc.	Upgrade